Methyllinoleat | 26181-81-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Methyllinoleat
• 英文别名: trans,trans-Octadeca-6,9-diensaeure-methylester；Methyl-trans,trans-octadeca-6,9-dienoat；6,9-Octadecadienoic acid, methyl ester；methyl (6E,9E)-octadeca-6,9-dienoate
• CAS: 26181-81-7
• 化学式: C₁₉H₃₄O₂
• 分子量: 294.478
• InChiKey: AKCKWBLFZNXDLY-IWCZYTNJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.9
• 重原子数：
  21
• 可旋转键数：
  15
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.74
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same
  申请人：SUNTORY LIMITED

  公开号：EP0825263A2

  公开（公告）日：1998-02-25

  The present invention discloses a process for producing lipid containing omega-9 highly unsaturated fatty acid by culturing in a medium a mutant strain obtained by mutation on a microorganism having the ability to produce arachidonic acid belonging to the genus Mortierella and so forth, in which Δ12 desaturation activity is decreased or lost, but at least one of Δ5 desaturation activity, Δ6 desaturation activity and chain length elongation activity is elevated. Moreover, the present invention also discloses a process for producing omega-9 highly unsaturated fatty acid by collecting omega-9 highly unsaturated fatty acid from the culture or lipid described above.

  本发明公开了一种生产含有ω-9高度不饱和脂肪酸的脂质的工艺，其方法是在培养基中培养通过突变获得的突变菌株，该突变菌株具有生产花生四烯酸的能力，属于莫氏菌属等，其中Δ12去饱和活性降低或丧失，但Δ5去饱和活性、Δ6去饱和活性和链长伸长活性中的至少一种活性升高。此外，本发明还公开了一种生产ω-9 高度不饱和脂肪酸的工艺，即从上述培养物或脂质中收集ω-9 高度不饱和脂肪酸。
• Process for production of omega 9 type polyunsaturated fatty acid
  申请人：SUNTORY LIMITED

  公开号：EP0535939B1

  公开（公告）日：1997-07-09
• CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF
  申请人：CALIFORNIA AMBER INC.

  公开号：US20210068444A1

  公开（公告）日：2021-03-11

  Provided herein are compositions comprising cannabinoids, terpenoids, and other flavonoids. Also provided herein are methods for producing compositions comprising cannabinoids, terpenoids, and other flavonoids at industrial scale. In certain embodiments, the compositions provided herein possess desirable organoleptic properties and therapeutic effects when ingested or topically applied. In certain embodiments, the compositions of the present disclosure have are useful in inhalable, ingestible, or topical products to relieve and treat various acute or chronic illnesses.
• US5322780A
  申请人：——

  公开号：US5322780A

  公开（公告）日：1994-06-21
• US6150144A
  申请人：——

  公开号：US6150144A

  公开（公告）日：2000-11-21